Institutional shares held 2.41 Million
17.1K calls
1.3K puts
Total value of holdings $8.63M
$61K calls
$4K puts
Market Cap $38.8M
10,830,900 Shares Out.
Institutional ownership 22.24%
# of Institutions 35


Latest Institutional Activity in LTRN

Top Purchases

Q1 2025
Perigon Wealth Management, LLC Shares Held: 39.4K ($141K)
Q1 2025
Commonwealth Equity Services, LLC Shares Held: 12.7K ($45.5K)
Q1 2025
Geode Capital Management, LLC Shares Held: 90.5K ($324K)
Q1 2025
Northern Trust Corp Shares Held: 15.6K ($55.8K)
Q1 2025
Renaissance Technologies LLC Shares Held: 88.8K ($318K)

Top Sells

Q1 2025
Susquehanna International Group, LLP Shares Held: 14.9K ($53.5K)
Q1 2025
New Edge Advisors, LLC Shares Held: 59.9K ($215K)
Q1 2025
Curio Wealth, LLC Shares Held: 1 ($3.58)
Q1 2025
Tower Research Capital LLC (Trc) Shares Held: 792 ($2.84K)
Q4 2024
Davenport & CO LLC Shares Held: 25.8K ($92.4K)

About LTRN

Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-300 as a combination therapy for non or never-smokers with non-small cell lung cancer adenocarcinoma. In addition, its preclinical development drug candidate is LP-184, an alkylating agent that damages DNA in cancer cells that overexpress certain biomarkers or that harbor mutations in DNA repair pathways. Further, the company operates ADC program, an antibody drug conjugate therapeutic approach for cancer treatment. Additionally, the company's artificial intelligence platform RADR uses big data analytics and machine learning for combining molecular data. The company was incorporated in 2013 and is headquartered in Dallas, Texas.


Insider Transactions at LTRN

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
3.83K Shares
From 1 Insiders
Exercise of in-the-money or at-the-money derivatives securities 3.83K shares
Sell / Disposition
316K Shares
From 2 Insiders
Open market or private sale 316K shares

Track Institutional and Insider Activities on LTRN

Follow Lantern Pharma Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LTRN shares.

Notify only if

Insider Trading

Get notified when an Lantern Pharma Inc. insider buys or sells LTRN shares.

Notify only if

News

Receive news related to Lantern Pharma Inc.

Track Activities on LTRN